Investment
Features
FeesSafety
Academy
More
Pluang+

Vault Strategic Mining amends private placement terms to raise up to $1.5M for exploration and corporate use.

Company Fundamentals
01 Sep 2026
TheNewswire
View Source
Bullish
pluang ai news

Vault Strategic Mining Corp has updated the terms of its non-brokered private placement, now offering up to 12 million units at $0.125 each, aiming to raise $1.5 million. Each unit includes one common share and one warrant exercisable at $0.20 within 12 months, with provisions for accelerated expiry if share prices rise. The funds will support exploration activities and general corporate expenses. The offering awaits TSX Venture Exchange approval and includes restrictions to prevent excessive ownership concentration by warrant holders.

More News

Alumis stock plunges 57% after lupus drug trial fails, but psoriasis drug progress continues.

Alumis stock plunges 57% after lupus drug trial fails, but psoriasis drug progress continues.

Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...

Market News
Bearish
4 hours ago
Zepp Health Q2 2026 revenue rises 6.9% but posts $11.3M net loss amid higher costs and investments

Zepp Health Q2 2026 revenue rises 6.9% but posts $11.3M net loss amid higher costs and investments

Zepp Health reported Q2 2026 revenue of $63.5M, up 6.9% year-over-year, driven by new product launches and improved product mix. Gross margin improved to 37.4%, but net loss widened to $11.3M due to foreign exchange headwinds and increased spending o...

Company Fundamentals
Neutral
4 hours ago
Alumis plunges 57% after trial failure; Enovis falls 16% on robotics acquisition news

Alumis plunges 57% after trial failure; Enovis falls 16% on robotics acquisition news

Alumis Inc. shares dropped 56.76% after its Phase 2b trial for a lupus drug failed to meet key goals, though some patient groups showed promise. Enovis Corporation shares fell 16.51% following its announcement to acquire eCential Robotics for €155 mi...

Market News
Bearish
4 hours ago
SPACs, biotech, geothermal, and AI stocks rally with major deals and volatility driving gains

SPACs, biotech, geothermal, and AI stocks rally with major deals and volatility driving gains

SPAC stocks like Rising Dragon Acquisition surged nearly 47% amid volatility, while biotech firm bioAffinity Technologies jumped 44% after a reverse stock split. Renewable energy company Fervo Energy gained 28% following a major geothermal power deal...

Market News
Bullish
4 hours ago
Enovis cuts price target to $27 amid €155M robotics acquisition, stock drops 16.5%.

Enovis cuts price target to $27 amid €155M robotics acquisition, stock drops 16.5%.

Enovis has lowered its price target to $27 from $30 following its binding offer to acquire eCential Robotics for €155 million. This acquisition aims to strengthen Enovis's position in surgical robotics and enhance its ASTRA technology ecosystem. Desp...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App